Career

Neurim, an established and  leading Pharmaceuticals Company , Operating in Ramat-Hahayal Tel-Aviv and Developing drugs for brain restoration & reinforcement, focusing on the central nervous system is looking for a:

Part-Time Marketing Assistant / 50-60% Position

We’re looking for a talented individual interested in advancing their career by working with us as part of our business/marketing team.  The role involves  research, creative, and analytic responsibilities and requires a quick, creative, curious mind.

Ideal candidates are those with entry-level marketing, communications, or information technologies experience (internships count as past experience), proficient in MS Office.

Typical assignments and responsibilities include:

  • Conducting Internet research
  • Improving and updating PowerPoint presentations
  • Managing content for our websites
  • Launching and tracking e-mail campaigns and newsletters
  • Assisting with content development for our social profiles
  • Writing press releases
  • Coordinating marketing events
  • And other professional assignments

This role requires a professional demeanor, strong organization, writing, and editing skills (English), good analytics abilities, attention to detail and solid listening skills.

A minimum of a BA/BS Degree is required. An undergraduate and/or graduate degree in Marketing, Advertising, Communications or a related business field is preferred.

People who succeed here have open and curious minds and the ability to see things that others miss.

This is your opportunity to work on both the creative and analytical sides of digital marketing.

Please send your CV to: or_k@rad.com

  • Text size: A A A
  • Circadin
  • Recent news

    • Neurim Pharmaceuticals Grants Exeltis Marketing Rights for Paediatric Prolonged-Release Melatonin (“PedPRM”) in Spain
    • Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin (“PedPRM”) to be Marketed by Biocodex in France
    • Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin (“PedPRM”) to be Marketed by Kuhnil Pharmaceutical in South Korea
  • Partners

    Partners